A/RES/60/221 initiatives and the Medicines for Malaria Venture, where necessary stimulated by new incentives to secure their development; 14. Calls upon the international community to support investment in the development of new medicines to prevent and treat malaria, especially for children and pregnant women, sensitive and specific diagnostic tests, effective vaccines, and new insecticides and delivery modes in order to enhance effectiveness and delay the onset of resistance, including through existing partnerships; 15. Also calls upon the international community to support ways to expand access to artemisinin-based combination therapy for populations at risk of exposure to resistant strains of falciparum malaria in Africa, including the commitment of new funds, innovative mechanisms for the financing and national procurement of artemisinin-based combination therapy and the scaling up of artemisinin production to meet the increased need; 16. Applauds the increased level of public-private partnerships for malaria control and prevention, including the financial and in kind contributions of companies operating in Africa, as well as increased engagement of nongovernmental service providers; 17. Calls upon malaria-endemic countries to encourage regional and intersectoral collaboration, both public and private, at all levels, especially in education, agriculture, economic development and the environment, to advance malaria control objectives; 18. Calls upon the international community to support increased interventions, in line with the recommendations of the Roll Back Malaria Partnership, in order to ensure their rapid, efficient and effective implementation, to strengthen health systems, to monitor for counterfeit anti-malarial medicines and prevent the distribution and use of them, and to support coordinated efforts, inter alia, by providing technical assistance to improve surveillance, monitoring and evaluation systems and their alignment with national plans and systems so as to better track and report changes in coverage and the need for scaling up recommended interventions and subsequent reductions in the burden of malaria; 19. Urges Member States, the international community and all relevant actors, including the private sector, to promote the coordinated implementation and enhance the quality of malaria-related activities, including via the Roll Back Malaria Partnership, in accordance with national policies and operational plans that are consistent with the technical recommendations of the World Health Organization and recent efforts and initiatives, including the Paris Declaration on Aid Effectiveness; 20. Requests the Secretary-General to report to the General Assembly at its sixty-first session on the implementation of the present resolution under the agenda item entitled “2001–2010: Decade to Roll Back Malaria in Developing Countries, Particularly in Africa”. 69th plenary meeting 23 December 2005 4